Skip to main content

Year: 2023

VPG Reports Fiscal 2023 Third Quarter Results

MALVERN, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, today announced its results for its 2023 third fiscal quarter ended September 30, 2023. Third Fiscal Quarter Highlights:Revenues of $85.9 million decreased 4.7% from a year ago. Gross profit margin was 41.9%, as compared to 41.4% reported a year ago. Adjusted gross profit margin* was 42.1%, as compared to 41.7% reported a year ago. Operating margin was 9.6%, as compared to 13.2% reported a year ago. Adjusted operating margin* was 11.2%, as compared to 13.7% reported a year ago. Diluted net earnings per share of $0.46 compared to $0.74 reported a year ago. Adjusted diluted net earnings per share* of $0.47 compared to $0.69 reported a year ago. EBITDA* was $13.7 million with an EBITDA...

Continue reading

Red Light Therapy Market Forecast Report 2023-2032 by Emergen Research

Robust growth trend is expected to continue as more consumers and healthcare professionals recognize the therapeutic potential of red light therapy. Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) — The global Red Light Therapy (RLT) market is expected to experience consistent revenue growth during the forecast period.The rise in market revenue can be attributed to the growing prevalence of chronic diseases worldwide, including fibromyalgia and arthritis. Fibromyalgia affects 2-4% of the population, with a higher incidence in women, according to the American College of Rheumatology. Osteoarthritis cases increased by 113% since 1990, reaching 528 million sufferers globally in 2019, as reported by the World Health Organization. Red Light Therapy, or RLT, is emerging as a promising treatment for these chronic conditions. It appears to alleviate...

Continue reading

Vivid Seats Announces Acquisition of Vegas.com

Strategic Transaction Furthers Vivid Seats’ Position as a Leading Online Marketplace CHICAGO, Nov. 07, 2023 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced its acquisition of Vegas.com, the leading entertainment marketplace for consumers exploring Las Vegas, in a cash and stock transaction valued at approximately $240 million1. Vegas.com is a two-sided marketplace and the ultimate destination for live event enthusiasts visiting Las Vegas. As the local market authority, Vegas.com provides the most comprehensive event inventory of shows, attractions, and tours in Las Vegas, one of the world’s most desirable destinations for...

Continue reading

Vivid Seats Delivers $1 Billion Quarterly Marketplace GOV & Acquires Vegas.com

Raising 2023 Guidance and Providing Initial 2024 Guidance for 26% Adjusted EBITDA Growth CHICAGO, Nov. 07, 2023 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today provided financial results for the third quarter ended September 30, 2023. “After delivering outstanding 28% Marketplace GOV growth in the third quarter, it has never been more clear that demand for live events is strong and that we are capturing that strength at Vivid Seats,” said Stan Chia, CEO. “Our focus on cultivating buyer loyalty continues to deliver results with repeat rates increasing and pacing ahead of expectations. Our business is better positioned than ever,...

Continue reading

Ingredion Incorporated Reports Strong Third Quarter Results and Raises Full-Year Outlook

Third quarter 2023 reported and adjusted operating income* grew 17% and 15%, respectively, compared to PY Third quarter 2023 reported and adjusted EPS* were $2.36 and $2.33, an increase of 48% and 35%, respectively The Company raises its full year adjusted EPS outlook to $9.05-$9.45, up from $8.80-$9.40WESTCHESTER, Ill., Nov. 07, 2023 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported results for the third quarter of 2023. The results, reported in accordance with U.S. generally accepted accounting principles (“GAAP”) for the third quarter of 2023 and 2022, include items that are excluded from the non-GAAP financial measures that the Company presents. “We continued to successfully manage our business in the third...

Continue reading

Alchip Technologies Opens Malaysia Design Center

Meets Increased Global Demand Taipei, Taiwan, Nov. 07, 2023 (GLOBE NEWSWIRE) — Alchip Technologies, Limited opened a new design center in October in Malaysia.  The new center came on line to meet the exploding global demand for the company’s high-performance ASIC services. The Malaysia design center is the latest addition to Alchip’s on-going global expansion that, last year, included the opening of a significantly upgraded North America presence. The Malaysia design center is expected to house 30 engineers by the end of the year, with that number increasing to meet expected customer demand. “This latest addition to our portfolio of high-performance ASIC design services is a direct response to global demand placed on Alchip.  It is testimony to our growing role as a high-performance ASIC leader,” explained Johnny Shen, Alchip President...

Continue reading

Cenovus Energy announces renewal of share buyback program

CALGARY, Alberta, Nov. 07, 2023 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) announced today that the Toronto Stock Exchange (“TSX”) has approved the renewal of the company’s normal course issuer bid (“NCIB”) to purchase up to 133,160,021 common shares during the 12-month period commencing November 9, 2023 and ending November 8, 2024. Cenovus’s renewal of its share buyback program is consistent with the company’s capital allocation framework, which supports enhancing value for investors by returning cash to shareholders, generating strong returns on capital investment and deleveraging its balance sheet. Cenovus believes there are times when the market price of its common shares may not fully reflect the underlying value of its business and future prospects. Depending on the trading price of its common shares and...

Continue reading

Syntec Optics, Inc. Listing on Nasdaq via Merger with OmniLit (Nasdaq: OLIT) Announces NASDAQ Opening Bell Ringing to Celebrate

ROCHESTER, NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) — Syntec Optics, Inc., maker of the leading mission-critical optics and photonics, announced today that the company will ring the opening Nasdaq bell on Wednesday, November 8, 2023, to celebrate its initial listing. Anyone can tune in to watch the memorable experience on livestream, Nasdaq MarketSite Tower in Times Square, and participating TV networks around the globe.   Syntec Optics CEO Joe Mohr commented, “It’s an honor to celebrate our listing on Nasdaq and recognize the amazing milestones the Syntec Optics team has accomplished in the recent launch of satellite optics for Low Earth Orbit and Viper, the light-weight night vision defense optics, with several other anticipated new product launches on the way. The company looks forward to sharing the event with several employees...

Continue reading

Esperion Reports Third Quarter 2023 Financial Results

– Q3 U.S. Net Product Revenue Grew 45% Y/Y to $20.3 Million; Q3 Total Revenue Grew 79% Y/Y to $34.0 Million – – Q3 Retail Prescription Equivalents Grew 33% Y/Y and 8% Q/Q, Demonstrating Sustained Momentum into 2H 2023 – – Received FDA Acceptance of Application for Expanded CV Risk Reduction Indications with PDUFA Date of March 31; EMA Approval of Expanded Labels on Track and Anticipated in 1H 2024 – – Presented Two New CLEAR Outcomes Analyses at the European Society of Cardiology (ESC), Further Differentiating NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet from Existing LDL-C Lowering Therapies – ANN ARBOR, Mich., Nov. 07, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today reported financial results for the third quarter ended September 30, 2023, and provided a business update. “We continued...

Continue reading

Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook

Continued strong momentum with third quarter sales growth of 9% and strong adjusted EBITDA margin expansionOrganic growth of 10% in Recon and 4% in P&RReported a third quarter net loss from continuing operations of $0.36 per share with adjusted earnings per diluted share of $0.56Increased full-year growth and profit outlookWilmington, DE, Nov. 07, 2023 (GLOBE NEWSWIRE) — —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended September 29, 2023. The Company will host an investor conference call and live webcast to discuss these results today at 8:00 am ET. Third Quarter 2023 Financial Results Enovis’ third quarter net sales of $418 million grew 9% from the same quarter in 2022, including 6.2% organic sales...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.